glucagon has been researched along with apraclonidine in 1 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (apraclonidine) | Trials (apraclonidine) | Recent Studies (post-2010) (apraclonidine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 427 | 98 | 56 |
| Protein | Taxonomy | glucagon (IC50) | apraclonidine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.004 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.004 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.004 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirose, H; Ito, K; Kido, K; Koyama, K; Maruyama, H; Saruta, T | 1 |
1 other study(ies) available for glucagon and apraclonidine
| Article | Year |
|---|---|
Glucose-induced insulin secretion and alpha 2-adrenergic receptor subtypes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Glucagon; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Male; Pancreas; Perfusion; Rats; Rats, Wistar; Receptors, Adrenergic, alpha | 1993 |